General - GeneDx, LLC

Skip to main navigation

Overview
News & Events
Corporate Governance
Financial Information
- SEC Filings
- Quarterly Results
Stock
IR Resources

code

General

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Read more about GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

Read more about GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

Read more about GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

Read more about GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GeneDx to Participate in Upcoming Investor Conferences

Read more about GeneDx to Participate in Upcoming Investor Conferences

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

Read more about GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

Read more about GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

Read more about GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

Galatea Bio and Fabric Genomics Partner to Deliver Comprehensive Genetic Testing for Common Diseases

Read more about Galatea Bio and Fabric Genomics Partner to Deliver Comprehensive Genetic Testing for Common Diseases

GeneDx to Participate in Upcoming Investor Conferences

Read more about GeneDx to Participate in Upcoming Investor Conferences

Pagination

Previous page
Page 3
Next page

Subscribe to General

Investor Contact

drafts investors@genedx.com

Privacy

Privacy Policy
Notice of Privacy Practices
Terms of Service
Compliance
Social Media Guidelines
No Surprise Billing Disclosure
Annual Physician Notice

Company

About Us
Leadership Team
IR/Media
Contact Us
Careers
Licenses & Certifications

Subscribe to our Email Alerts

Email Address* Required

© 2026 GeneDx, LLC

Search Investors

Search this site